paclitaxel has been researched along with Weight Loss in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 10 (47.62) | 29.6817 |
| 2010's | 4 (19.05) | 24.3611 |
| 2020's | 5 (23.81) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, J; Correa Ordonez, I; Davis, M; Vanenkevort, E; Varun, S; Wojtowicz, M; Young, A | 1 |
| Aquilini Mummolo, A; Bruno, G; Cincione, RI; Conteduca, V; Giordano, G; Landriscina, M; Lizzi, V; Losavio, F; Pacilli, M; Piscazzi, A; Senia, T | 1 |
| Chen, S; Gao, L; Huang, S; Jiao, C; Li, D; Li, M; Luo, T; Luo, Y; Su, J; Su, L; Xie, Y; Yong, T | 1 |
| Abada, P; Chatterjee, A; Chaudhry, A; Klempner, SJ; Knoderer, H; Liepa, AM; Mansoor, W; Roeland, EJ; Wei, R | 1 |
| Baurain, JF; Danse, E; Derouane, F; Komuta, M; Yildiz, H; Yombi, JC | 1 |
| Mehta, RS; Nangia, CI; Tran, PN; Zhuang, L | 1 |
| Corn, B; Domb, AJ; Gofrit, O; Nyska, A; Shikanov, A; Shikanov, S | 1 |
| Avezza, F; Bossi, M; Canta, A; Carozzi, V; Cavaletti, G; Ceresa, C; Chiorazzi, A; Crippa, L; Gilardini, A; Nicolini, G; Oggioni, N; Rodriguez-Menendez, V | 1 |
| Berg, MJ; Gallagher, MJ; Gross, RA; Heckler, CE; Janelsins, MC; Jean-Pierre, P; Morrow, GR; Opanashuk, LA; Roscoe, JA; Thompson, BD | 1 |
| Bordeaux, JS; Honda, KS; Robinson, MR | 1 |
| Chou, TC; Danishefsky, SJ; Dong, H; Hartung, J; Lee, JH; Lei, X; Wilson, RM; Zhang, X; Zhang, Y | 1 |
| Bader, SB; Louie, J; Molendyk, J; Phillips, M; Regan, J; Ross, HJ; Ruzich, J; Seligman, M; Seung, SK; Skokan, L; Smith, JW; Soo, E | 1 |
| Akerley, W; Choy, H; Johnson, DH; Kim, DW; Shaktour, B; Shyr, Y | 1 |
| Alberts, DS; Barakat, R; Hess, LM; Ozols, RF; Tian, C | 1 |
| Lacko, AG; McConathy, WJ; Mooberry, L; Nair, MP; Paranjape, S | 1 |
| Byhardt, R; Komaki, R; Langer, C; Machtay, M; Movsas, B; Nicolaou, N; Sarna, L; Swann, S; Wasserman, T; Werner-Wasik, M | 1 |
| Fujimoto, S | 1 |
| DeNardo, GL; DeNardo, SJ; Kroger, LA; Kukis, DL; Lamborn, KR; Miers, LA; O'Donnell, RT; Richman, CM | 1 |
| Olszewski, W | 1 |
| Amsrud, T; Chen, V; Forler, PA; Menon, K; Phares, VG; Shih, C; Teicher, BA | 1 |
| Cao, L; Cruz, T; Ludwin, SK; Moscarello, MA; Sun, D; Whitaker, JN | 1 |
2 review(s) available for paclitaxel and Weight Loss
| Article | Year |
|---|---|
Early Weight Loss as a Prognostic Factor in Patients with Advanced Gastric Cancer: Analyses from REGARD, RAINBOW, and RAINFALL Phase III Studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Esophagogastric Junction; Humans; Paclitaxel; Prognosis; Stomach Neoplasms; Weight Loss | 2021 |
When a metastatic breast cancer is mimicking a pancreatic cancer: case report and review of the literature.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Carcinoma, Ductal, Breast; Cholangiopancreatography, Endoscopic Retrograde; Common Bile Duct; Diagnosis, Differential; Female; Humans; Jaundice; Liver Neoplasms; Lymph Nodes; Middle Aged; Paclitaxel; Pancreatic Neoplasms; Retroperitoneal Space; Tomography, X-Ray Computed; Trastuzumab; Ultrasonography; Weight Loss | 2020 |
1 trial(s) available for paclitaxel and Weight Loss
| Article | Year |
|---|---|
Selective dose escalation of chemoradiotherapy for esophageal cancer: role of treatment intensification.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Paclitaxel; Radiotherapy Dosage; Survival Rate; Weight Loss | 2004 |
18 other study(ies) available for paclitaxel and Weight Loss
| Article | Year |
|---|---|
Is Weight Loss During Chemotherapy for Pancreatic Cancer Prognostic?
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Gemcitabine; Humans; Paclitaxel; Pancreatic Neoplasms; Prognosis; Prospective Studies; Retrospective Studies; Weight Loss | 2023 |
Pancreatic Enzyme Replacement and Nutritional Support With nab-Paclitaxel-based First-Line Chemotherapy Regimens in Metastatic Pancreatic Cancer.
Topics: Albumins; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Gemcitabine; Humans; Nutritional Support; Paclitaxel; Pancreatic Neoplasms; Quality of Life; Retrospective Studies; Weight Loss | 2023 |
Polysaccharide from spore of Ganoderma lucidum ameliorates paclitaxel-induced intestinal barrier injury: Apoptosis inhibition by reversing microtubule polymerization.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Epithelial Cells; Female; Humans; Intestinal Mucosa; Mice; Mice, Inbred BALB C; Microtubules; Paclitaxel; Polysaccharides; Reishi; Spores, Fungal; Tight Junction Proteins; Weight Loss | 2020 |
Dramatic Response to Carboplatin, Paclitaxel, and Radiation in a Patient With Malignant Myoepithelioma of the Breast.
Topics: Anorexia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carboplatin; Dose Fractionation, Radiation; Fatigue; Female; Humans; Immunohistochemistry; Lymphatic Metastasis; Middle Aged; Myoepithelioma; Paclitaxel; Radiotherapy, Adjuvant; Rare Diseases; Tomography, X-Ray Computed; Treatment Outcome; Weight Loss | 2016 |
Intratumoral delivery of paclitaxel for treatment of orthotopic prostate cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Drug Delivery Systems; Male; Models, Animal; Neoplasms, Experimental; Ointments; Paclitaxel; Prostatic Neoplasms; Rats; Tumor Burden; Weight Loss | 2009 |
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cisplatin; Disease Models, Animal; Drug Administration Schedule; Female; Ganglia, Spinal; Neurotoxicity Syndromes; Paclitaxel; Peripheral Nervous System Diseases; Rats; Rats, Wistar; Weight Loss | 2009 |
IGF-1 partially restores chemotherapy-induced reductions in neural cell proliferation in adult C57BL/6 mice.
Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Bromodeoxyuridine; Cell Proliferation; Cyclophosphamide; Dentate Gyrus; Doxorubicin; Fluorouracil; Humans; Insulin-Like Growth Factor I; Mice; Mice, Inbred C57BL; Neurogenesis; Neurons; Paclitaxel; Weight Loss | 2010 |
Angiosarcoma in an obese woman with worsening lymphedema after weight-loss and skin-reduction surgeries.
Topics: Dermatologic Surgical Procedures; Disease Progression; Fatal Outcome; Female; Gastric Bypass; Hemangiosarcoma; Humans; Lower Extremity; Lymphedema; Middle Aged; Obesity, Morbid; Paclitaxel; Plastic Surgery Procedures; Skin Neoplasms; Weight Loss | 2011 |
Multifaceted cytoprotection by synthetic polyacetylenes inspired by the ginseng-derived natural product, panaxytriol.
Topics: Animals; Biological Products; Cell Death; Cytoprotection; Enediynes; Fatty Alcohols; Female; Fluorouracil; Humans; Isomerism; Longevity; Mice; Mice, Nude; Paclitaxel; Panax; Polyynes; Weight Loss; X-Rays; Xenograft Model Antitumor Assays | 2011 |
Long term follow up and analysis of long term survivors in patients treated with paclitaxel-based concurrent chemo/radiation therapy for locally advanced non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Databases, Factual; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Retrospective Studies; Survival Analysis; Weight Loss | 2005 |
Weight change during chemotherapy as a potential prognostic factor for stage III epithelial ovarian carcinoma: a Gynecologic Oncology Group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Body Weight; Carboplatin; Carcinoma; Cisplatin; Clinical Trials, Phase III as Topic; Cystadenocarcinoma, Serous; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Predictive Value of Tests; Prognosis; Randomized Controlled Trials as Topic; Retrospective Studies; United States; Weight Gain; Weight Loss | 2007 |
Evaluation of synthetic/reconstituted high-density lipoproteins as delivery vehicles for paclitaxel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Body Weight; Carbon Radioisotopes; Cell Line, Tumor; Cell Survival; Cholesterol; Cholesterol Esters; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Evaluation, Preclinical; Female; Humans; Inhibitory Concentration 50; Injections, Intraperitoneal; Lipoproteins, HDL; Mice; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Molecular Weight; Nanoparticles; Paclitaxel; Particle Size; Pharmaceutical Vehicles; Phosphatidylcholines; Weight Loss | 2008 |
Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801.
Topics: Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Deglutition; Female; Humans; Lung Neoplasms; Male; Neoplasm Staging; Paclitaxel; Quality of Life; Radiation-Protective Agents; Sexual Behavior; Socioeconomic Factors; Treatment Outcome; Weight Loss | 2008 |
[Schedule dependency of i.v.-paclitaxel against SC-M 109 mouse lung cancer].
Topics: Animals; Cell Division; Drug Administration Routes; Drug Administration Schedule; Infusions, Intravenous; Lung Neoplasms; Mice; Neoplasm Transplantation; Paclitaxel; Prognosis; Weight Loss | 1994 |
Importance of temporal relationships in combined modality radioimmunotherapy of breast carcinoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bone Marrow; Combined Modality Therapy; Female; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Paclitaxel; Radioimmunotherapy; Tumor Cells, Cultured; Weight Loss; Yttrium Radioisotopes | 1997 |
Clinical efficacy of micronized purified flavonoid fraction (MPFF) in edema.
Topics: Anthropometry; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Capillary Permeability; Carcinoma; Docetaxel; Double-Blind Method; Edema; Electronics, Medical; Female; Flavonoids; Humans; Leg; Lymphedema; Mastectomy; Optics and Photonics; Ovarian Neoplasms; Paclitaxel; Placebos; Randomized Controlled Trials as Topic; Taxoids; Venous Insufficiency; Weight Loss | 2000 |
Treatment regimens including the multitargeted antifolate LY231514 in human tumor xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cell Division; Cisplatin; Cyclophosphamide; Docetaxel; Female; Fluorouracil; Folic Acid Antagonists; Glutamates; Guanine; Humans; Injections, Intraperitoneal; Lung Neoplasms; Male; Mice; Mice, Nude; Neoplasm Transplantation; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Pemetrexed; Taxoids; Transplantation, Heterologous; Tumor Cells, Cultured; Vinblastine; Vinorelbine; Weight Loss | 2000 |
Inhibition of experimental allergic encephalomyelitis in the Lewis rat by paclitaxel.
Topics: Amino Acid Sequence; Animals; Antigens; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Encephalomyelitis, Autoimmune, Experimental; Female; Freund's Adjuvant; Guinea Pigs; Immunization, Passive; Inflammation; Lymphocyte Activation; Micelles; Molecular Sequence Data; Multiple Sclerosis; Myelin Basic Protein; Paclitaxel; Paralysis; Peptide Fragments; Rats; Rats, Inbred Lew; T-Lymphocytes; Weight Loss | 2000 |